Adaptive Biotechnologies Corporation ADPT
Set alert
26.40 USD +1.34 +5.33%
As of Nov 3, 10:44 AM ET
25.33 Day range 26.46
12.00 52-week range 30.74
- YTD
- +62.53%
- 1 year
- +52.22%
- Open
- 25.46
- Prev close
- 25.06
- Mkt cap
- 4.21B
- Vol
- 249.30K
- Avg vol
- 2.17M
- EPS
- -0.41
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 25.33
- High
- 26.46
- Forward P/E
- -139.00
- Beta
- 2.15
- Short ratio
- 4.56
- Inst. own
- 99.03%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 4, 2026
- 50-d avg
- 26.38
- 200-d avg
- 19.60
- 1y target
- 30.21
5D chart
Signals (119)
| Name | Time | Ago |
|---|---|---|
| SMA: Bearish | Nov 2, 3:55 PM | 18 hours ago |
| SMA: Bullish | Nov 2, 3:45 PM | 18 hours ago |
| SMA: Bullish | Nov 2, 3:45 PM | 18 hours ago |
| MACD: Buy Signal | Nov 2, 3:45 PM | 18 hours ago |
| MACD: Sell Signal | Nov 2, 3:35 PM | 19 hours ago |
| SMA: Bearish | Nov 2, 3:25 PM | 19 hours ago |
| SMA: Bearish | Nov 2, 3:25 PM | 19 hours ago |
| SMA: Bullish | Nov 2, 3:10 PM | 19 hours ago |
| SMA: Bullish | Nov 2, 3:05 PM | 19 hours ago |
| SMA: Bearish | Nov 2, 2:25 PM | 20 hours ago |
| SMA: Bearish | Nov 2, 1:30 PM | 21 hours ago |
| SMA: Bullish | Nov 2, 1:20 PM | 21 hours ago |
| SMA: Bearish | Nov 2, 1:05 PM | 21 hours ago |
| SMA: Bullish | Nov 2, 12:55 PM | 21 hours ago |
| SMA: Bearish | Nov 2, 12:15 PM | 22 hours ago |
| SMA: Bullish | Nov 2, 12:05 PM | 22 hours ago |
| MACD: Buy Signal | Nov 2, 11:55 AM | 22 hours ago |
| RSI: Oversold | Nov 2, 11:10 AM | 23 hours ago |
| RSI: Oversold | Nov 2, 10:50 AM | 23 hours ago |
| SMA: Bearish | Nov 2, 10:00 AM | 1 day ago |
Newest 20 of 119.
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 30.21 +14.5% upside
Now 26.40
- Target (low)
- 21.00
- Target (mean)
- 30.21
- Target (high)
- 35.00
Ratings (0m) 8 8 buy · 0 hold · 0 sell
- Strong buy2
- Buy6
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 8
- 1 month ago 9
- 2 months ago 8
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.09552 | -0.11 – -0.08 | 0.06 | -259.2% | 71.60M | -23.8% | 7 |
| Next quarter | -0.06409 | -0.08 – -0.04 | -0.09 | +28.8% | 79.29M | +10.6% | 7 |
| Current year | -0.54243 | -0.57 – -0.51 | -0.39 | -39.1% | 293.25M | +5.9% | 7 |
| Next year | -0.18029 | -0.32 – -0.01 | -0.54243 | +66.8% | 360.14M | +22.8% | 7 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 13, 2026 | TD Cowen | Maintained | Buy | Buy |
| Oct 13, 2026 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Oct 1, 2026 | Guggenheim | Maintained | Buy | Buy |
| Sep 29, 2026 | Goldman Sachs | Initiated | — | Buy |
| Sep 22, 2026 | BTIG | Maintained | Buy | Buy |
| Aug 4, 2026 | Piper Sandler | Maintained | Overweight | Overweight |
| Jul 30, 2026 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Jul 30, 2026 | TD Cowen | Maintained | Buy | Buy |
| Jul 30, 2026 | Guggenheim | Maintained | Buy | Buy |
| Jul 30, 2026 | BTIG | Maintained | Buy | Buy |
| Jul 9, 2026 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Jun 29, 2026 | Guggenheim | Maintained | Buy | Buy |
| Jun 17, 2026 | BTIG | Reiterated | Buy | Buy |
| May 12, 2026 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| May 6, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| May 6, 2026 | TD Cowen | Maintained | Buy | Buy |
| May 6, 2026 | Guggenheim | Reiterated | Buy | Buy |
| May 6, 2026 | BTIG | Reiterated | Buy | Buy |
| Feb 6, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Feb 6, 2026 | BTIG | Maintained | Buy | Buy |
| Jan 26, 2026 | Guggenheim | Maintained | Buy | Buy |
| Nov 11, 2025 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Nov 6, 2025 | JP Morgan | Maintained | Overweight | Overweight |
| Nov 6, 2025 | BTIG | Maintained | Buy | Buy |
| Oct 22, 2025 | BTIG | Maintained | Buy | Buy |
| Oct 15, 2025 | Piper Sandler | Maintained | Overweight | Overweight |
| Oct 13, 2025 | JP Morgan | Maintained | Overweight | Overweight |
| Sep 30, 2025 | Guggenheim | Initiated | — | Buy |
| Aug 6, 2025 | JP Morgan | Maintained | Overweight | Overweight |
| Aug 6, 2025 | TD Cowen | Maintained | Buy | Buy |
